Nausea and vomiting are common complications of anaesthesia. Dexamethasone is an effective prophylaxis but is immunosuppressive and may increase postoperative infection risk. This retrospective cohort study examined the association between the administration of a single intraoperative anti-emetic dose of dexamethasone (4 to 8 mg) and postoperative infection in 439 patients undergoing single procedure, non-emergency surgery in a university trauma centre. Exclusion criteria included comorbidities, immunosuppressive medications or procedures that confer an increased infection risk. In the 10-week study period and three-month follow-up period, there were 98 documented infections (22.3% of the cohort), of which 43 were detected only on post-discharge follow-up. Anti-emetic dexamethasone was given to 108 patients (24.6%). Stepwise, multivariate logistic regression modelling identified significant associations between female gender, symptomatic reflux, respiratory disease and the risk of infection. The adjusted odds ratio for dexamethasone was 0.88 (0.5 to 1.5, P=0.656). We did not demonstrate an association between anti-emetic doses of dexamethasone and postoperative infection.
Postoperative nausea and vomiting (PONV) affects approximately 30 to 70% of patients in the 1, 2 . It carries substantial morbidity, including delayed discharge and unplanned admission following day surgery 3 . It is one of the complications most feared by patients 4 . The factors which increase the risk of PONV are now well characterised 1 and this, coupled with increasing appreciation of its importance 5 , have led to a focus on prophylaxis and effective treatment. While several predictive models are available 2, 6, 7 , none are absolute 1 . Hence, consensus guidelines have been published and recently updated 8,9 . Once anaesthetic technique has been optimised to reduce PONV, many different anti-emetics can be used to reduce the risk of developing PONV and to treat it once established 9, 10 . The use of single anti-emetic agents prophylactically has been found to reduce the risk of PONV by approximately 26% and, when further anti-emetics are added, can cumulatively reduce the risk by up to 70% 11 , particularly in high-risk populations. Dexamethasone is an anti-emetic that is used as a single dose prophylactically during surgery in patients at high risk of developing PONV 11 . It has a short plasma halflife, but a biological and effect half-life of up to 72 hours, and appears to be particularly effective against late PONV. There are many advantages in using in vivo inhibits cell proliferation and decreases cytokines (Il-1, IL-6, IL-3 and INF) 12 , collagenisation, epithelialisation and fibroblast content in wounds 13 . Recent systematic reviews and metanalyses have not identified postoperative infections as a complication of dexamethasone use as an anti-emetic 11, 14 . The studies addressed in these reports however, did not specifically examine infection as an outcome. given the importance of infective complications upon long-term outcomes 15 and the increasing use of dexamethasone as an effective and cheap anti-emetic, establishing its safety in this respect must now be a priority. We sought to examine this in a cohort study.
METHODS
This was a retrospective, observational cohort study of surgical patients undergoing non-emergency surgery at Royal Perth Hospital. Royal Perth Hospital is a tertiary, university teaching hospital and the state major trauma centre in Western Australia. Patients from all adult medical and surgical specialties are represented in this hospital except for acute liver transplantation. The study was approved by the institution's ethics committee. We included all adult patients undergoing non-emergency surgery under general anaesthesia. This surgical procedure was identified as the index procedure. Exclusion criteria included any surgical procedure beginning outside of 0700 to 1800 hours on weekdays or performed on the weekend, solid organ transplantation, cardiothoracic surgical cases, procedures for which malignancy was the primary indication, procedures for conditions at high risk of infective complications (such as open fractures, contaminated lacerations and bites), patients who were taking antibiotics for another infective process at the time of the index procedure, patients who were concurrently suffering from malignancy, chronic renal failure, autoimmune diseases or who were taking glucocorticoids or disease-modifying agents at the time of the index procedure. We also excluded cases that were admitted to the intensive care unit postoperatively for respiratory or haemodynamic failure. Patients who received intraoperative dexamethasone for indications other than prevention of nausea and vomiting were excluded from consideration if repeated postoperative doses were administered, or if the dose administered exceeded conventional anti-emetic doses. In order to avoid confounding from an additional surgical stress response, patients were excluded if they had a surgical procedure within a one-month period prior to the index procedure, or during the three-month follow-up period. If a subsequent surgical procedure was performed within the three-month follow-up period for an infective complication of the index procedure then this patient was considered to have experienced a postoperative infection.
After identification of eligible cases using our computerised Theatre Management System, each patient's file was reviewed and key data recorded. For each case, irrespective of infection status, we also recorded perioperative antibiotic use. This was classified as either intraoperative but no postoperative antibiotics (IO only), postoperative but no intraoperative antibiotics (PO only), both intra-and postoperative antibiotics (IO+PO) or no antibiotics at all. We also noted whether patients were on perioperative prophylaxis that was changed or started on new antibiotics de novo. Each patient was followed for a period of three months after their recorded surgery date in order to identify the occurrence of postoperative infections. This follow-up comprised examination of case-notes, telephone contact with the patient's medical general practitioner (gP) and, where possible, direct telephone contact with the patient. gP and patient contact involved asking a standard set of four screening questions to identify the occurrence of a likely infective process. Where infection was identified we recorded the type of infection and the time to first infection. Each patient was followed up until either an infection was identified or three months had passed from their date of surgery.
Defining infection and detection of cases
For the purpose of this study we defined infection as any bacterial infection diagnosed and recorded in the patient's medical records by the attending doctor. Using this definition, we examined the documentation of each patient's postoperative care from both the inpatient and outpatient case notes available in their hospital files. Postoperative infection was defined as either 'early' (within two weeks of surgery) or 'late' (more than two weeks after surgery). Antibiotic therapy alone was not used as a means of defining the presence or absence of infection. The occurrence of infection was identified from gP or patient follow-up when antibiotic therapy was prescribed by the patient's gP, emergency department or at an outpatient follow-up visit and infection was suspected due to symptoms or features of local wound infection, cough with purulent sputum, new onset febrile illness or microbiological evidence of a urinary tract infection or other infective focus. Statistics Continuous variables were analysed by t-tests and categorical variables were analysed by chi-squared tests or Fisher's exact test. Multivariate logistic regression was employed to examine the relationship between patient and procedure characteristics and the incidence of postoperative infection. All variables that were demonstrated to be significantly associated with postoperative infection on univariate analysis were entered into the model. Dexamethasone use was also entered as this was the primary predictor of interest to the study and was subjected to forced entry into the final model. Variables whose coefficients had an associated P >0.25 were eliminated in stepwise fashion. Cox regression was performed to identify whether dexamethasone use, adjusted for significant predictors of postoperative infection, influenced the time to development of infection. A P <0.05 was considered significant and all statistical tests were performed with SPSS for Windows (version 17, SPSS Inc, Chicago, IL, USA, 2009).
RESULTS
In the 10-week period between 31 March and 6 June 2008, 1015 eligible index cases were identified as meeting preliminary entry screening criteria. Of these, 573 were excluded due to failure to meet inclusion criteria, five cases were excluded for having received glucocorticoids in the preceding three months and in 129 cases the three-month follow-up was not achieved. This left a cohort of 439 patients with complete follow-up. There were 98 cases of documented infection (22.3%) of which 55 occurred in hospital and 43 were detected at subsequent follow-up. Of those infections detected on follow-up and which did not appear on the hospital system, 18 were classified as 'early' and 25 as 'late'.
There was no difference between those who did and did not develop infection with respect to age, weight, body mass index, use of tourniquet and maximum white cell count or C-reactive protein concentrations (Table 1) . Patients who did develop postoperative infection were, however, more likely to be female and have undergone surgery of a longer duration (P=0.011 and 0.043 respectively, Table 1 ). They were more likely to suffer from symptomatic reflux, chronic obstructive pulmonary disease (COPD) and to be active smokers (P=0.019, 0.001 and 0.036 respectively, Table 2 ). The surgical details and medication intake did not statistically differ between groups (Tables 3 and 4 ). Patterns of antibiotic usage were associated with significant differences in the risk of infection (Table 5) .
Patients who developed infection were more likely to have received intra-and postoperative, or just postoperative antibiotics only, compared to those who did not develop infection (P=0.004, 0.003 respectively). They were also more likely to have been started on new postoperative antibiotics or to have their current prophylactic antibiotics changed to another class (P=0.001 in both cases). In contrast however, patients who did not develop infection were more likely not to have received any perioperative antibiotics (P=0.001). Females were more likely than males to receive intraoperative dexamethasone (P <0.001, Table 6a ). Cox regression analysis did not identify any difference between those who did and did not receive dexamethasone, in terms of the time to developing infection postoperatively. We were unable to identify any association between the use of intraoperative All values n (%). ENT=ear, nose and throat surgery. * χ 2 analysis for all surgery. dexamethasone and postoperative infections (P=0.977, Table 4 ). This association was not significantly altered when postoperative infections were classified according to temporal occurrence (P=0.884, Table 6a ). When stepwise logistic regression was employed to identify predictors of postoperative infection, dexamethasone use was forced into the model at each step, because of the necessity to adjust the association between gender and infection in light of the increased administration of dexamethasone to females. Using this model, female gender (OR 1.7, 1.1 to 2.8, P=0.033), a current diagnosis of COPD (OR 3.7, 1.04 to 13.2, P=0.043) and symptomatic gastro-oesophageal reflux (OR 2.5, 1.5 to 4.3, P=0.001) were positive predictors of postoperative infection risk ( Table 7 ). The adjusted odds ratio for dexamethasone use as a binary categorical variable was 0.88 (0.5 to 1.5, P=0.656). Analysis of dexamethasone use at either 4 or 8 mg doses did not alter the significance of this finding. The Homer-Lemeshow goodness-of-fit chi-square statistic for this model is 1.6, P=0.807.
DISCUSSION
The most important finding of this study is that no association between postoperative infection and intraoperative dexamethasone administration was apparent in our cohort. We think this is the first study to specifically examine the association between anti-emetic doses of dexamethasone and the risk of postoperative infection in a retrospective cohort fashion. This is an important topic to address for several reasons. Dexamethasone use is increasing. This is attributable not only to consensus guidelines recommending its use for prophylaxis 9 and its documented efficacy, particularly when used for 'late' PONV 11 , but also due to its expanding role as an analgesic agent in procedures such as tonsillectomy and laparoscopic cholecystectomy [16] [17] [18] . Furthermore, it is emerging that the occurrence of any infective complication in the postoperative period has an impact upon mortality up to one year following the event 15 . Thus, it is possible that the use of a single anaesthetic intraoperative intervention may result in consequences that extend far beyond the postoperative period. A surprising finding in a recent trial has been that dexamethasone administration to tonsillectomy patients increased bleeding risk, an effect which was dose-related 19 . This may have been due to interference with the healing process, an anticoagulant effect or secondary bleeding as a result of wound infection. Given the increase in use and its possible immunomodulatory effects, we need to establish its safety. A previous single-centre, small, randomised controlled trial examined this issue, with postoperative infection as a secondary outcome 20 . In that study, follow-up ended at two weeks, the groups were high risk and surgical site infection was the only infection considered. There are considerable differences to the heterogeneous cohort that our study represents. Hence, we believe that the currently available literature still does not provide data on the influence of dexamethasone on perioperative immunocompetence, nor on infection rate.
The secondary findings of the study were quite clear. Female gender, COPD history and symptomatic reflux were strong predictors of postoperative infection risk. Dexamethasone was forced into the regression model at each step to correct for the increased proportion of females who received dexamethasone. When corrected for dexamethasone administration, female gender remained a risk factor for infection. This finding agrees with other studies where gender influences outcome from sepsis 21, 22 and females have a worse prognosis, perhaps due to sex hormone effects 22 , although some studies identify male gender as being a predictor 23 and some have failed to find any difference 24 . The finding that symptomatic reflux is associated with infection is a finding that we cannot explain and which merits further examination. It might, perhaps, be due to associated medication effects, although we did not have complete data on this and hence can make no further comment. The numbers with COPD were small, but contrary to expectation, respiratory infections were no more common in these patients than other infections. The overall infection rate of 22.3% was high and perhaps this may have been higher had so many patients not failed follow-up. However, it may have also been that we included infections that occurred at a time following surgery when they may not necessarily be considered 'postoperative'. The inclusion of urinary tract infections and infections occurring following hospital discharge would also produce a higher capture rate than conventional studies examining postoperative infection. Hence, direct comparisons may not be valid. Even if we had only included those infections diagnosed in hospital, the infection risk would have been 13%. The perioperative stress response is a complex disruption of the metabolic, endocrine, coagulation and immune systems, producing catabolism and immunoparesis [25] [26] [27] [28] . glucocorticoids have clear immunosuppressive effects and are sometimes used to attenuate the perioperative inflammatory response in cardiac surgery. There are four principal mechanisms by which these compounds may influence the inflammatory response 29 and these lead to altered expression of inflammatory genes, chemokine and cytokine expression and altered cellular immunity 30 . They may also have a potent influence on T-cell development 31, 32 . A recent meta-analysis 33 confirmed that high or low doses of glucocorticoids are equi-effective in cardiac surgical patients in terms of shortened duration of mechanical ventilation and the prevention of atrial fibrillation 33 . No association with increased infective complications was identified, although this was not a primary endpoint in the majority of the studies examined. Our understanding of the duration of postoperative immunoparesis or inflammatory perturbations remains incomplete. The choice of period of follow-up was an arbitrary one. We sought to detect whether postoperative immunosuppression caused by dexamethasone would result in increased infection rates even after discharge from hospital. Hence, we included hospital and gP/patient follow-up data. Many of these infections, perhaps perceived by the patient as minor, would not be detected without contacting the gP or patient individually. They also might not be detected by examination of hospital data. This strategy was justified since 43 (44%) were detected only on follow-up.
The principal strength of this study was the exclusion of patients with factors which might distort any perceived relationship between dexamethasone and infection. We sought to exclude patients whose preoperative comorbidites would predispose to postoperative infection and therefore confound the relationship 34, 35 , such as emergency procedures, surgery on contaminated wounds, the presence of renal failure and advanced liver disease, all of which increase infection risk. We permitted the inclusion of patients who received a dose of dexamethasone intraoperatively which could be considered anti-emetic although the indication for administration may not have been anti-emesis. We excluded patients who had multiple procedures during the study period, as the influence of single or multiple anti-emetic doses of dexamethasone combined with multiple surgical stress responses would be difficult to interpret. We used strict diagnostic criteria for infective complications and also followed patients up for three months.
The design was primarily that of a retrospective cohort and it may suffer from the information bias that commonly affects such studies. Following application of the exclusion criteria, we excluded more patients than we had expected to. The criteria were quite strict and thus we may have over-corrected for comorbidities. Of the 568 eligible patients, 129 (23%) did not have three-month follow-up data and had to be excluded. The diagnostic criteria for postoperative infection by gP or patient follow-up involved a component of investigator interpretation. Our patient cohort was heterogeneous and conclusions in relation to particular surgical groups cannot be definitively reached. Although this was a study with a negative result, the importance of reporting such studies in the anaesthesia literature has been recently emphasised 36 . The findings of this study, however, must be interpreted in the context of these potential weaknesses. This is particularly true given that our recently completed case-control study reached a different conclusion, namely that dexamethasone use is associated with an increased risk of infectious complications 37 . The matched case-control study may have been methodologically more robust, as the diagnostic criteria were more objective, there were fewer losses due to incomplete data and the matching removed the confounding that occurs with age and gender. Furthermore, the matching for procedures would have controlled for an imbalance of risk between the two groups in the study.
In conclusion, in this retrospective cohort investigation of the association between antiemetic doses of dexamethasone and postoperative infection, we were unable to identify a significant relationship. Since there are alternative anti-emetic agents to dexamethasone, this question warrants further investigation with a large, randomised controlled trial. Such a trial would need to examine patients undergoing procedures with varying levels of infective risk. In particular, it is necessary to identify in which groups its use as an anti-emetic might pose an unacceptable risk.
